A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165
Journal Article
Overview
publication date
has subject area
-
Aptamers, Nucleotide
-
Binding Sites
-
Binding Sites - Binding, Competitive
-
Biochemical Phenomena - Binding, Competitive
-
Biochemical Phenomena - Protein Binding
-
Biochemical Phenomena - Signal Transduction
-
Biological Factors - Vascular Endothelial Growth Factor A
-
Biomedical and Dental Materials - Polyethylene Glycols
-
Cell Physiological Phenomena - Signal Transduction
-
Cells, Cultured
-
Chemical Phenomena - Dimerization
-
Chemistry Techniques, Analytical - Binding, Competitive
-
Endothelium - Endothelium, Vascular
-
Ethylene Glycols - Polyethylene Glycols
-
Heparin
-
Humans
-
Macromolecular Substances - Polyethylene Glycols
-
Macular Degeneration
-
Magnetic Resonance Spectroscopy
-
Manufactured Materials - Polyethylene Glycols
-
Metabolism - Dimerization
-
Metabolism - Protein Binding
-
Models, Molecular
-
Neovascularization, Pathologic
-
Peptides - Vascular Endothelial Growth Factor A
-
Protein Conformation
-
Protein Isoforms
-
Protein Structure, Secondary
-
Protein Structure, Tertiary
-
Proteins - Vascular Endothelial Growth Factor A
-
Pyrimidines
-
RNA
-
Saccharomycetales - Pichia
-
Thermodynamics
-
Tunica Intima - Endothelium, Vascular
-
Yeasts - Pichia
has restriction
Date in CU Experts
-
September 9, 2013 9:19 AM
Full Author List
-
Lee JH; Canny MD; De Erkenez A; Krilleke D; Ng YS; Shima DT; Pardi A; Jucker F
author count
citation count
published in
Other Profiles
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)
Digital Object Identifier (DOI)
Additional Document Info
start page
end page
volume
issue